宏源药业 (301246.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(宏源药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 426,063,885.002,054,881,990.911,558,714,943.06997,633,605.73503,909,819.722,063,723,485.64-901,319,450.12451,160,829.25
 营业利润(元) 35,165,805.81105,644,504.60122,096,871.1577,596,668.6475,875,567.69479,933,805.96-335,821,000.17192,556,841.96
 利润总额(元) 35,078,651.5898,558,063.56114,984,252.6576,092,913.3375,764,451.63477,976,420.57-333,497,999.30192,303,399.92
 净利润(元) 31,199,061.6287,168,626.2496,300,179.2265,023,439.8864,744,366.06434,795,621.19-302,536,958.56176,797,540.25
 归属于母公司股东的净利润(元) 31,199,061.6287,168,626.2496,300,179.2265,023,439.8864,744,366.06434,795,621.19-302,536,958.56176,797,540.25
盈利能力:
 销售毛利率(%) 15.7312.9914.5814.5219.2823.3224.1126.7431.61
 销售净利率(%) 7.324.246.186.5212.8521.0727.9133.5739.19
 净资产收益率(%) 0.712.69-2.062.08----
 总资产报酬率ROA(%) 0.582.00-1.661.75----
 投入资本回报率ROIC(%) 0.622.172.411.621.5717.8613.7713.507.36
营运能力:
 存货周转率(次) 1.416.57-3.092.86----
 应收账款周转率(次) 2.037.84-4.994.72----
 总资产周转率(次) 0.070.43-0.220.11----
偿债能力:
 资产负债率(%) 22.1222.8521.4124.0526.4345.44-39.7137.17
 股东权益比率(%) 77.8877.1578.5975.9573.5754.56-60.2962.83
 已获利息倍数(倍) -20.16-28.04-50.16-53.9340.00-42.60--59.86174.62
 流动比率 3.523.504.203.683.311.26-1.57-
 速动比率 3.223.253.853.353.030.97-1.23-
发展能力:
 营业收入增长率(%) -15.45-0.4316.8010.6911.6930.79-28.99-
 营业利润增长率(%) -53.65-77.99-70.30-76.89-60.60-12.49-0.5549.92100.42
 税后利润增长率(%) -51.81-79.95-74.15-78.51-63.38-11.96-0.5852.76113.38
 净资产增长率(%) 0.40106.24113.06118.92135.8525.98-43.25-
 总资产增长率(%) -5.1545.8156.1673.79101.4159.28-69.49-

前瞻产业研究院